| Literature DB >> 30220561 |
Ling-Jie Sang1, Huai-Qiang Ju2, Guang-Ping Liu3, Tian Tian2, Guo-Lin Ma4, Yun-Xin Lu2, Ze-Xian Liu2, Ruo-Lang Pan1, Rui-Hua Li1, Hai-Long Piao5, Jeffrey R Marks6, Luo-Jia Yang1, Qingfeng Yan1, Wenqi Wang7, Jianzhong Shao1, Yubin Zhou4, Tianhua Zhou8, Aifu Lin9.
Abstract
Cancer cells entail metabolic adaptation and microenvironmental remodeling to survive and progress. Both calcium (Ca2+) flux and Ca2+-dependent signaling play a crucial role in this process, although the underlying mechanism has yet to be elucidated. Through RNA screening, we identified one long noncoding RNA (lncRNA) named CamK-A (lncRNA for calcium-dependent kinase activation) in tumorigenesis. CamK-A is highly expressed in multiple human cancers and involved in cancer microenvironment remodeling via activation of Ca2+-triggered signaling. Mechanistically, CamK-A activates Ca2+/calmodulin-dependent kinase PNCK, which in turn phosphorylates IκBα and triggers calcium-dependent nuclear factor κB (NF-κB) activation. This regulation results in the tumor microenvironment remodeling, including macrophage recruitment, angiogenesis, and tumor progression. Notably, our human-patient-derived xenograft (PDX) model studies demonstrate that targeting CamK-A robustly impaired cancer development. Clinically, CamK-A expression coordinates with the activation of CaMK-NF-κB axis, and its high expression indicates poor patient survival rate, suggesting its role as a potential biomarker and therapeutic target.Entities:
Keywords: Ca(2+); LncRNA; NF-κB; PDX; cancer; glycolysis; metabolism; signal transduction; tumor microenvironment
Mesh:
Substances:
Year: 2018 PMID: 30220561 DOI: 10.1016/j.molcel.2018.08.014
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970